Market Tracker

07/22 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

23.89
Delayed Data
As of Jul 22
 +1.24 / +5.47%
Today’s Change
8.00
Today|||52-Week Range
41.97
-38.08%
Year-to-Date
Why Investors Flocked to Sarepta Therapeutics Last Week
Jul 21 / MotleyFool.com - Paid Partner Content
3 Risky Biotech Stocks That Could Make You Rich
Jul 12 / MotleyFool.com - Paid Partner Content
Sarepta Therapeutics (SRPT) Stock Falls on Q2 Earnings Loss
Jul 20 / TheStreet.com - Paid Partner Content
Why Sarepta Therapeutics Shares Slipped 10.9% in June
Jul 09 / MotleyFool.com - Paid Partner Content
Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus
Jul 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close22.65
Today’s open22.91
Day’s range22.61 - 24.48
Volume3,094,681
Average volume (3 months)6,197,230
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+5.22%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book5.43

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.29-0.91%
TBPHTheravance Biopharma...+0.66+2.96%
INSYINSYS Therapeutics I...+0.33+2.11%
PBYIPuma Biotechnology I...+7.00+20.28%
Data as of 4:01pm ET, 07/22/2016

Financials

Last reporting dateJuly 19, 2016
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts